135 related articles for article (PubMed ID: 32028300)
21. Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema.
Binitha MP; Nandakumar G; Thomas D
Indian J Dermatol Venereol Leprol; 2008; 74(3):248-50. PubMed ID: 18583794
[TBL] [Abstract][Full Text] [Related]
22. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
Rey JB; Luria RB
J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
[TBL] [Abstract][Full Text] [Related]
23. Scleromyxedema.
Yang Y; Chen H; Zhang W; Sun JF
Indian J Dermatol Venereol Leprol; 2016; 82(6):738-739. PubMed ID: 26858056
[No Abstract] [Full Text] [Related]
24. Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.
Kim S; Park TH; Lee SM; Kim YH; Cho MK; Whang KU; Kim HS
Dermatol Ther; 2020 May; 33(3):e13378. PubMed ID: 32250023
[TBL] [Abstract][Full Text] [Related]
25. Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients.
Rongioletti F; Merlo G; Cinotti E; Fausti V; Cozzani E; Cribier B; Metze D; Calonje E; Kanitakis J; Kempf W; Stefanato CM; Marinho E; Parodi A
J Am Acad Dermatol; 2013 Jul; 69(1):66-72. PubMed ID: 23453242
[TBL] [Abstract][Full Text] [Related]
26. Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
Wang SS; Chen QY; Xiang LH
Front Immunol; 2022; 13():1099918. PubMed ID: 36713453
[TBL] [Abstract][Full Text] [Related]
27. Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
Mahévas T; Arnulf B; Bouaziz JD; Livideanu CB; Osio A; Servy A; Cribier B; Sassolas B; Jachiet M; Michel L; Aucouturier P; Lipsker D; Frances C; Sbidian E; Rybojad M; Descamps V; D'Incan M; Humbert P; Beylot-Barry M; Passeron T; de Moreuil C; Taha RY; Hermine O; Dupuy A; Barbarot S; Debarbieux S; Carpentier O; Brault F; Schmutz JL; Thomas-Beaulieu D; Modiano P; Zarnitsky C; Lifermann F; Baubion E; Limal N; Le Bras F; Le Moigne M; Tauber M; Talbot A; Prud'homme R; Peltier S; De Masson A; Battistella M; Bagot M; Mékinian A; Fain O
Blood; 2020 Apr; 135(14):1101-1110. PubMed ID: 32027747
[TBL] [Abstract][Full Text] [Related]
28. Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report.
Rabee H; Tayem L; Gharbeyah M; Abugaber D
BMC Dermatol; 2020 Dec; 20(1):18. PubMed ID: 33276772
[TBL] [Abstract][Full Text] [Related]
29. Unusual granulomatous variant of scleromyxedema.
Stetsenko GY; Vary JC; Olerud JE; Argenyi ZB
J Am Acad Dermatol; 2008 Aug; 59(2):346-9. PubMed ID: 18485525
[TBL] [Abstract][Full Text] [Related]
30. Scleromyxedema vs scleredema: a diagnostic challenge.
Conde Fernandes I; Sanches M; Velho G; Lobo I; Alves R; Selores M
Eur J Dermatol; 2011; 21(5):822-3. PubMed ID: 21771713
[No Abstract] [Full Text] [Related]
31. Diffuse skin thickening and linear papules in a 59-year-old woman.
Brelsford M; Mason A; Pariser R
Arch Dermatol; 2012 Nov; 148(11):1317-8. PubMed ID: 23165842
[No Abstract] [Full Text] [Related]
32. Scleromyxedema diagnosis following unexplained encephalopathy.
Rodrigues M; Machado A; Ventura F; Duarte ML; Ferreira C
Eur J Dermatol; 2008; 18(1):78-9. PubMed ID: 18086595
[No Abstract] [Full Text] [Related]
33. Scleromyxedema Without Monoclonal Gammopathy Treated with Intravenous Immunoglobulins.
Letzelter M; Grimaux X
Acta Dermatovenerol Croat; 2021 Apr; 291(1):51-53. PubMed ID: 34477065
[TBL] [Abstract][Full Text] [Related]
34. Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.
Rongioletti F; Cozzani E; Parodi A
J Cutan Pathol; 2010 Oct; 37(10):1084-7. PubMed ID: 19638067
[TBL] [Abstract][Full Text] [Related]
35. Scleromyxedema with histology resembling granuloma annulare.
Mullangi S; Granter SR; Laubach JP; Lipworth AD
Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780962
[TBL] [Abstract][Full Text] [Related]
36. Scleroderma-like acute renal crisis in a patient with scleromyxedema.
Gwinner W; Erdbruegger U; Mengel M; Hafer C; Kittner J; Witte T; Voelker B; Haller H
Nephrol Dial Transplant; 2007 Jul; 22(7):2063-7. PubMed ID: 17389621
[No Abstract] [Full Text] [Related]
37. Scleroderma renal crisis-like acute renal failure associated with mucopolysaccharide accumulation in renal vessels in a patient with scleromyxedema.
Lee YH; Sahu J; O'Brien MS; D'Agati VD; Jimenez SA
J Clin Rheumatol; 2011 Sep; 17(6):318-22. PubMed ID: 21869708
[TBL] [Abstract][Full Text] [Related]
38. [Dermato-neuro syndrome during scleromyxedema: efficacy of plasmapheresis and intravenous immunoglobulin].
Charles S; Hainaut E; Cante V; Valette C; Levillain P; Guillet G
Ann Dermatol Venereol; 2014; 141(8-9):523-7. PubMed ID: 25209816
[TBL] [Abstract][Full Text] [Related]
39. Dermato-neuro syndrome associated with scleromyxedema.
Karaman B; Guler A; Ertam I; Celebisoy N
Indian J Dermatol Venereol Leprol; 2015; 81(5):519-21. PubMed ID: 26261151
[No Abstract] [Full Text] [Related]
40. Scleromyxedema.
Liu CH; Tsai YY; Tien YC
Rheumatology (Oxford); 2022 Jul; 61(7):e201-e200. PubMed ID: 34554227
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
